XHKG1612
Market cap32mUSD
Jan 07, Last price
0.40HKD
1D
-1.25%
1Q
-12.22%
Jan 2017
-63.43%
IPO
-66.24%
Name
Vincent Medical Holdings Ltd
Chart & Performance
Profile
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, and anesthesia systems. The company's orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People's Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 717,973 14.10% | 629,242 -19.09% | |||||||
Cost of revenue | 669,441 | 651,744 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 48,532 | (22,502) | |||||||
NOPBT Margin | 6.76% | ||||||||
Operating Taxes | 8,707 | 2,874 | |||||||
Tax Rate | 17.94% | ||||||||
NOPAT | 39,825 | (25,376) | |||||||
Net income | 57,275 -429.20% | (17,398) -128.66% | |||||||
Dividends | (8,042) | (32,686) | |||||||
Dividend yield | 3.24% | 7.69% | |||||||
Proceeds from repurchase of equity | (3,273) | (2,436) | |||||||
BB yield | 1.32% | 0.57% | |||||||
Debt | |||||||||
Debt current | 35,546 | 55,292 | |||||||
Long-term debt | 18,178 | 10,200 | |||||||
Deferred revenue | (6,415) | ||||||||
Other long-term liabilities | 6,415 | ||||||||
Net debt | (154,880) | (124,042) | |||||||
Cash flow | |||||||||
Cash from operating activities | 124,975 | 76,273 | |||||||
CAPEX | (63,695) | (18,599) | |||||||
Cash from investing activities | (62,366) | (18,609) | |||||||
Cash from financing activities | (45,367) | (67,836) | |||||||
FCF | 20,272 | 52,185 | |||||||
Balance | |||||||||
Cash | 175,784 | 159,341 | |||||||
Long term investments | 32,820 | 30,193 | |||||||
Excess cash | 172,705 | 158,072 | |||||||
Stockholders' equity | 381,382 | 336,904 | |||||||
Invested Capital | 407,771 | 379,389 | |||||||
ROIC | 10.12% | ||||||||
ROCE | 8.29% | ||||||||
EV | |||||||||
Common stock shares outstanding | 645,661 | 653,741 | |||||||
Price | 0.39 -40.77% | 0.65 -35.00% | |||||||
Market cap | 248,579 -41.50% | 424,932 -35.73% | |||||||
EV | 94,947 | 301,492 | |||||||
EBITDA | 87,184 | 18,450 | |||||||
EV/EBITDA | 1.09 | 16.34 | |||||||
Interest | 1,682 | 2,852 | |||||||
Interest/NOPBT | 3.47% |